Home

August J. Troendle

CIK 1622058 · President & CEO · last filed 2026-08-31

August J. Troendle is a President & CEO who has filed 175 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider sold $403.2K of MEDP on Aug 31, 2026. Across all open-market trades the lifetime net is −$1.23B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.12B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.12B

Companies

2

Total Filings

175

Lifetime Open-Market Net

-$1.23B

Filer Profile

Reported Address
5375 MEDPACE WAY
CINCINNATI, OH 45227
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MEDP President & CEO 5,272,913 $591.29 $3.12B -$1.21B 158 2026-08-31
CHRS Director 298,422 $1.42 $423.8K -$18.18M 10 2018-02-05

Recent Filings

175 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-31 MEDP Sell (S) −650 -$403.2K EDGAR
2026-08-27 MEDP Sell (S) −4,673 -$2.90M EDGAR
2026-08-25 MEDP Sell (S) −15,978 -$9.97M EDGAR
2026-08-21 MEDP Sell (S) −42,783 -$26.28M EDGAR
2026-08-14 MEDP Sell (S) −11,824 -$7.11M EDGAR
2026-08-12 MEDP Sell (S) −23,144 -$13.98M EDGAR
2026-07-29 MEDP Sell (S) −7,238 -$4.35M EDGAR
2026-07-27 MEDP Notice (144) −307,959 -$184.78M EDGAR
2026-04-28 MEDP Grant (A) — $0 EDGAR
2025-12-04 MEDP Sell (S) −668 -$394.6K EDGAR
Showing 1–10 of 175
Page 1 of 18
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.